A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Smith, MD
Celgene Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Calgary, Peter Lougheed Centre
Calgary, Alberta, Canada
- University of Alberta
Edmonton, Alberta, Canada
- Vancouver General Hospital/university of British Columbia
Vancouver, British Columbia, Canada
- St. Boniface Hospital
Winnipeg, Manitoba, Canada
- Victoria Hospital
London, Ontario, Canada
- Notre-Dame Hospital Du Chum
Montreal, Quebec, Canada
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Uc Davis Medical Center, Division of Pulmonary and Critical Care Medicine
Sacramento, California, United States
- Stanford University, Pulmonary & Critical Care Clinic
Stanford, California, United States
- University of Miami Miller School of Medicine
Miami, Florida, United States
- University of Louisville
Louisville, Kentucky, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Mount Sinai Medical Center
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- Geisenger Center for Clinical Studies
Danville, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas
Galveston, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- Vermont Lung Center
Colchester, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jan 2011
- Primary completion
- 31 Jan 2012
- Completion
- 24 Aug 2012
- Last update posted
- 19 Nov 2019
- Registered enrollment
- 28
- Registry id
- NCT01203943
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.